Clinical trial NCT01822392: On-line Treatment for Conduct Problems
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Conduct Disorder
Oppositional Defiant Disorder
Keywords: Online treatment
Treatment of conduct problems
Parent training
Lead sponsor: Yale University
Sponsor class: OTHER
Collaborators: name: National Institute of Mental Health (NIMH)
First posted: 2013-04-02
Enrollment: 86
Sex: ALL
Minimum age (years): 6
Maximum age (years): 12
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The research evaluates the use of online versions of delivering an effective psychological treatment for children clinically referred for serious oppositional, aggressive, and antisocial behavior. The goal is to develop models of delivery that reach families in need that are not being served by in-person treatment. The project has immediate implications for the treatment of children but more generally addresses several issues critical to treatments that are based on Internet, telepsychiatry, and related technologies.


Eligibility criteria: Inclusion Criteria:

* Diagnosis of Conduct Disorder of Oppositional Defiant Disorder (for the child)
* Residence in the state of CT
* Access to a computer and high-speed Internet access
* English fluency (at least one parent)
* No history of significant developmental delay (for the child)
* Parental consent

Exclusion Criteria:

* Participation in another form of psychotherapy or counseling that is directed toward the reduction of social, emotional, or behavioral problems
* Evidence of recent suicidality (for the child)
* Current or lifetime diagnosis of a Pervasive Developmental Disorder
* Primary diagnoses of a mood or anxiety disorder
* Acute family crisis
* Parent or guardian who can participate in treatment shows current psychosis or an uncontrolled medical condition

Primary outcomes:
measure: Child Behavior Checklist
timeFrame: Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
measure: Child Global Assessment Scale
timeFrame: Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
measure: Interview for Antisocial Behavior
timeFrame: Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
measure: Research Diagnostic Interview
timeFrame: Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
Secondary outcomes:
measure: Parenting Stress Index
timeFrame: Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
measure: Beck Depression Inventory
timeFrame: Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
measure: Management of Child Behavior Scale
timeFrame: Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
measure: Parent-Therapist Relationship Scale (Therapist version)
timeFrame: Midtreatment (Week 4 of treatment)
measure: Parent-Therapist Relationship Scale (Therapist version)
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Parent-Therapist Relationship Scale (Parent version)
timeFrame: Midtreatment (Week 4 of treatment)
measure: Parent-Therapist Relationship Scale (Parent version)
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Barriers to Participation in Treatment (Therapist version)
timeFrame: Midtreatment (Week 4 of treatment)
measure: Barriers to Participation in Treatment (Therapist version)
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Barriers to Participation in Treatment (Parent version)
timeFrame: Midtreatment (Week 4 of treatment)
measure: Barriers to Participation in Treatment (Parent version)
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Weekly Participation in Treatment
timeFrame: Weekly (during treatment)
measure: Treatment Adherence Inventory (Therapist version)
timeFrame: Midtreatment (Week 4 of treatment)
measure: Treatment Adherence Inventory (Therapist version)
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Treatment Adherence Inventory (Parent version)
timeFrame: Midtreatment (Week 4 of treatment)
measure: Treatment Adherence Inventory (Parent version)
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Therapist Evaluation Inventory
timeFrame: Midtreatment (Week 4 of treatment)
measure: Therapist Evaluation Inventory
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Parent Evaluation Inventory
timeFrame: Midtreatment (Week 4 of treatment)
measure: Parent Evaluation Inventory
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
measure: Acceptability of Treatment Modality
timeFrame: Midtreatment (Week 4 of treatment)
measure: Acceptability of Treatment Modality
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
Other outcomes:
measure: Perspectives on Treatment Interview
timeFrame: Posttreatment (immediately after treatment is completed; Week 8)
Locations:
city: New Haven
country: United States
facility: Yale Parenting Center
state: Connecticut
Study officials:
affiliation: Yale University
name: Alan E. Kazdin, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References: